Fundraising FoxDefinigen
Uppsala, SE · 3 known investors
Find your way into Definigen
Sign up to see every warm intro you have to Definigen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Definigen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.
Founders & leadership
OS
JC
Jordi Carreras-PuigvertChief Scientific Officer & Co-FounderJordi Carreras-Puigvert is Chief Scientific Officer and Co-Founder of Definigen, which develops iPSC-derived human hepatocytes and intestinal organoids for drug safety testing and disease modeling. He holds an Associate Professor position at Uppsala University, where he co-leads the Pharmaceutical Bioinformatics group.
Investors · 3
Founder mafia
4 people who came through Definigen went on to found or lead other companies.
Frequently asked questions
- What does Definigen do?
- Definigen manufactures iPSC-derived human hepatocytes for drug discovery and disease modeling. The product line supports preclinical toxicity testing, metabolism studies, and disease research in pharmaceutical development.
- Who founded Definigen?
- Definigen was founded by Christopher Trummer, Ola Spjuth, Jordi Carreras-Puigvert, Morgan Ekmefjord.
- Who are Definigen's investors?
- Definigen's investors include Almi Invest, Nordic Science Investments, 24 Haymarket.
- Where is Definigen headquartered?
- Definigen is headquartered in Uppsala, SE.